Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- DIVISLAB.NSE
- Price
- 5589.30
- Stock movement up
- +203.15 (3.77%)
- Company name
- Divi's Laboratories Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 1483.79B
- Ent value
- 1502.10B
- Price/Sales
- 17.23
- Price/Book
- 10.82
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 80.90
- Forward P/E
- -
- PEG
- -
- EPS growth
- 3.41%
- 1 year return
- 47.24%
- 3 year return
- 7.86%
- 5 year return
- 23.28%
- 10 year return
- 21.42%
Last updated: 2025-04-12
DIVIDENDS
DIVISLAB.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 80.90 |
| Price to OCF | 780.94 |
| Price to FCF | 780.94 |
| Price to EBITDA | 254.07 |
| EV to EBITDA | 257.21 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 17.23 |
| Price to Book | 10.82 |
| EV to Sales | 17.44 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 265.47M |
| EPS (TTM) | 69.04 |
| FCF per share (TTM) | 7.15 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 86.14B |
| Gross profit (TTM) | 43.80B |
| Operating income (TTM) | 16.51B |
| Net income (TTM) | 18.34B |
| EPS (TTM) | 69.04 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 50.85% |
| Operating margin (TTM) | 19.17% |
| Profit margin (TTM) | 21.29% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 380.00M |
| Net receivables | 0.00 |
| Total current assets | 93.41B |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 155.86B |
| Accounts payable | 8.55B |
| Short/Current long term debt | 80.00M |
| Total current liabilities | 12.91B |
| Total liabilities | 18.69B |
| Shareholder's equity | 137.17B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 1.90B |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 1.90B |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 13.37% |
| Return on Assets | 11.77% |
| Return on Invested Capital | 13.36% |
| Cash Return on Invested Capital | 1.38% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5550.00 |
| Daily high | 5625.00 |
| Daily low | 5386.15 |
| Daily Volume | 795K |
| All-time high | 6256.50 |
| 1y analyst estimate | 5512.44 |
| Beta | 0.35 |
| EPS (TTM) | 69.04 |
| Dividend per share | - |
| Ex-div date | 1 Aug 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| DIVISLAB.NSE | S&P500 | |
| Current price drop from All-time high | -10.66% | -12.89% |
| Highest price drop | -88.56% | -56.47% |
| Date of highest drop | 24 Feb 2009 | 9 Mar 2009 |
| Avg drop from high | -41.27% | -11.07% |
| Avg time to new high | 22 days | 12 days |
| Max time to new high | 2931 days | 1805 days |
COMPANY DETAILS
Marketcap
1483.79B
Marketcap category
Large-cap
Description
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Employees
9741
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found